|
Neoadjuvant Chemotherapy (NAC) Clinical Trials
2 actively recruiting trials across 1 location
Houston, Texas2 trials
EUS-RFA PANCARDINAL-1 Trial
Memorial Hermann Hospital
Phase 2
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma
The University of Texas Health Science Center at Houston
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.